Physician

Anthony S Ekong, M.D.

According to 2025 Medicare claims, Anthony Ekong, M.D. (NPI: 1336171875) practices ophthalmology in the Bangor, ME market, with the plurality of this provider's patient population coming from Penobscot, ME. This provider's primary affiliated billing organization is RETINA & UVEITIS CONSULTANTS OF MAINE (NPI: 1487182580; TIN: 82-0894324) and primary practice location at 04401-4236.

Ekong's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 409 traditional Medicare patients, billed 26,658 HCPCS/CPT codes, and received $1,402,963 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 176 prescription claims across 65 beneficiaries totaling $17,996 in drug costs, led by Simbrinza (Brinzolamide/Brimonidine Tart). Open Payments data shows 1 records totaling $23. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $887,570 to $1,402,963. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $23,597 and ending at $17,996. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$701K$1.4M2015 Medicare payment: $887,570 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $723,422 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $204,936 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $404,989 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $556,172 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $681,829 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,033,507 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,082,983 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,094,125 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,402,963 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159317,712$887,570
20164966,040$723,422
20172702,559$204,936
20183725,042$404,989
20193855,282$556,172
20205236,096$681,829
20214708,334$1,033,507
20224119,307$1,082,983
202339117,848$1,094,125
202440926,658$1,402,963

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$23K$46K2015 Drug cost: $23,597 (USD; Tot_Drug_Cst)2016 Drug cost: $14,473 (USD; Tot_Drug_Cst)2017 Drug cost: $8,123 (USD; Tot_Drug_Cst)2018 Drug cost: $11,348 (USD; Tot_Drug_Cst)2019 Drug cost: $15,955 (USD; Tot_Drug_Cst)2020 Drug cost: $31,317 (USD; Tot_Drug_Cst)2021 Drug cost: $46,007 (USD; Tot_Drug_Cst)2022 Drug cost: $32,475 (USD; Tot_Drug_Cst)2023 Drug cost: $22,529 (USD; Tot_Drug_Cst)2024 Drug cost: $17,996 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015121362$23,597
201686300$14,473
201750110$8,123
201848158$11,348
201951173$15,955
202074258$31,317
202167266$46,007
202250208$32,475
202364189$22,529
202465176$17,996

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system318504$89
67028Injection of drug into eye2381,688$84
92012Established patient problem focused exam of visual system257756$62
92134Imaging of retina3731,979$29
92250Photography of the retina276407$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
SimbrinzaBrinzolamide/Brimonidine Tart11799$2,225
LatanoprostLatanoprost472,684$551
SpironolactoneSpironolactone211,550$326
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat12871$99

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$23Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anthony S. Ekong, M.D.?

Tedicare shows public-source Medicare data for Anthony S. Ekong, M.D. (NPI 1336171875), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony S. Ekong, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony S. Ekong, M.D.?

Anthony S. Ekong, M.D. is linked to RETINA & UVEITIS CONSULTANTS OF MAINE (billing NPI 1487182580) in the available physician profile data.

Does Anthony S. Ekong, M.D. have Open Payments data?

Anthony S. Ekong, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.